Paper of the month

• May 2011
  Worthmann H, Chen S, Martens-Lobenhoffer J, Li N, Deb M, Tryc AB, Goldbecker A, Dong Q, Kielstein JT, Bode-Böger SM, Weissenborn K. High Plasma Dimethylarginine Levels are Associated with Adverse Clinical Outcome After Stroke. J Atheroscler Thromb. 2011 May 12. [Epub ahead of print]



• April 2011
  Kielstein JT, Tolk S, Hafer C, Heiden A, Wiesner O, Kühn C, Hadem J, Hoeper MM, Fischer S. Effect of acute kidney injury requiring extended dialysis on 28 day and 1 year survival of patients undergoing interventional lung assist membrane ventilator treatment. BMC Nephrol. 2011 ;12:15



• February 2011
  Lorenzen JM, Thum T, Eisenbach GM, Haller H, Kielstein JT. Conversion from conventional in-centre thrice-weekly haemodialysis to short daily home haemodialysis ameliorates uremia-associated clinical parameters. Int Urol Nephrol. 2011 Feb 27. [Epub ahead of print]



• January 2011
  Sorrentino JN, Kielstein JT, Lukasz A, Gohrbandt B, Haller H, Schmidt BM. High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis. Crit Care Med. 2011; 39(1):184-6.



• December 2010
  Tutarel O, Denecke A, Bode-Böger SM, Martens-Lobenhoffer J, Schieffer B, Westhoff-Bleck M, Kielstein JT. Symmetrical Dimethylarginine Outperforms CKD-EPI and MDRD-Derived eGFR for the Assessment of Renal Function in Patients with Adult Congenital Heart Disease. Kidney Blood Press Res. 2010; 34(1):41-45.



• November 2010
  Schiffer L, Kielstein JT, Haubitz M, Lührs H, Witte T, Haller H, Kümpers P, Schiffer M. Elevation of serum CXCL13 in SLE as well as in sepsis. Lupus. 2010 Nov 15. [Epub ahead of print]



• September 2010
  Rifai K, Bode-Boeger SM, Martens-Lobenhoffer J, Ernst T, Kretschmer U, Hafer C, Fliser D, Manns MP, Kielstein JT. Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption. Scand J Gastroenterol. 2010; 45(9):1110-5.



• August 2010
  David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Böger SM, Kliem V, Haller H, Kielstein JT. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant. 2010; 25(8):2571-6.



• July 2010
  Kielstein JT, Veldink H, Lorenzen JM, Lichtinghagen R, Martens-Loebnhoffer J, Bode-Böger SM, Kliem V. SDMA is an early marker of change in GFR after living-related kidney donation. NDT Advance Access published on July 9, 2010. PDF



• June 2010
  Wilson A, Shin D, Weatherby C, Harada R, Ng M, Nair N, Kielstein J, Cooke JP. Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med OnlineFirst published on May 19, 2010. PDF



• May 2010
  Rifai K, Bode-Boeger SM, Martens-Lobenhoffer J, Ernst T, Kretschmer U, Hafer C, Fliser D, Manns MP, Kielstein JT. Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption. Scand J Gastroenterol. 2010 May PDF



• April 2010
  Lorenzen J, Krämer R, Kliem V, Bode-Böger SM, Veldink H, Haller H, Fliser D, Kielstein JT. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest 40:294-300, 2010 PDF



• March 2010
  David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Böger SM, Kliem V, Haller H, Kielstein JT. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant. 2010 Feb 22 PDF



• February 2010
  Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walther R, Kielstein JT. Serum neutrophil gelatinase-associated lipocalin (NGAL) at inception of renal replacement therapy predicts mortality in critically ill patients with acute kidney injury Crit Care. 14:R9 doi:10.1186/cc886114:R9 doi:10.1186/cc8861 PDF



• January 2010
  Burkhardt O & Kielstein JT. A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients. Expert Rev Anti Infect Ther. 2010;8(1):11-4. PDF



• December 2009
  KielsteinJT, Engbers C, Bode-Boger SM, Martens-Lobenhoffer J, Haller H, Joukhadar C, Traunmüller F, Knitsch W, Hafer C, Burkhardt O. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis –a pharmacokinetic study. Nephrol Dial Transplant, doi: 10.1093/ndt/gfp704 PDF



• April 2009
  Kielstein JT, Hesse G, Bahr MJ, Tsikas D, Terkamp C, Martens-Lobenhoffer J, Manns MP, Haller H, Panning B, Bode-Böger SM, Gebel M. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med. 2009 Apr;37(4):1483-5. PDF



• March 2009
  David S, Kümpers P, Hellpap J, Horn R, Leitolf H, Haller H, Kielstein JT. Angiopoietin 2 and Cardiovascular Disease in Dialysis and Kidney Transplantation. Am J Kidney Dis. 2009 Mar 4. [Epub ahead of print] PDF



• February 2009
  Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, Fliser D, Kielstein JT. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant. 2009 Feb 13. [Epub ahead of print] PDF



• January 2009
  Burkhardt O, Hafer C, Langhoff A, Kaever V, Kumar V, Welte T, Haller H, Fliser D, Kielstein JT. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant. 2009 Jan;24(1):267-71. PDF